Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul 1;98(1):55-56.
doi: 10.1002/ccd.29813.

The death knell of bare metal stents: The Cobra stent's encouraging results with short-term antiplatelet therapy

Affiliations
Editorial

The death knell of bare metal stents: The Cobra stent's encouraging results with short-term antiplatelet therapy

Nachiket J Patel et al. Catheter Cardiovasc Interv. .
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Urban P, Mehran R, Colleran R, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk. Eur Heart J. 2019;40(31):2632-2653.
    1. Sorrentino S, Claessen BE, Chandiramani R, et al. Long-term safety and efficacy of durable polymer cobalt-chromium Everolimus-eluting stents in patients at high bleeding risk: a patient-level stratified analysis from four postapproval studies. Circulation. 2020;141(11):891-901.
    1. Valle JA, Shetterly S, Maddox TM, et al. postdischarge bleeding after percutaneous coronary intervention and subsequent mortality and myocardial infarction: Insights from the HMO Research Network-Stent Registry. Circ Cardiovasc Interv. 2016;9(6):e003519. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003519
    1. Maillard L, de Labriolle A, Brasselet C, et al. Evaluation of the safety and efficacy of the Cobra PzF nanocoated coronary stent in routine, consecutive, prospective, and high-risk patients: the e-Cobra study. Catheter Cardiovasc Interv. 2021;98:45-54.
    1. Presented by Dr. Robert Byrne at the Transcatheter Cardiovascular Therapeutics Virtual Meeting (TCT Connect), October 17, 2020.

Substances

LinkOut - more resources